S. 1477Senate111th Congress (2009-2011)In Committee

A bill to establish a user fee for follow-up reinspections under the Federal Food, Drug, and Cosmetic Act.

Introduced July 21, 2009

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

July 21, 2009

View full timeline
SenateIntro Referral

Introduced in Senate

July 21, 2009

SenateIntro Referral

Sponsor introductory remarks on measure. (CR S7783)

July 21, 2009

SenateIntro Referral

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

July 21, 2009

Floor Debate

5 members

What members said about S. 1477 on the floor

1 Republican4 Democrats
Russell D. Feingold
Sen. Russell D. FeingoldD-WI · Jul 21, 2009

Mr. President, today I am introducing a bill that would charge a reinspection fee for goods that fail FDA inspection for good manufacturing practices. Currently, businesses do not have to pay for the…

Bill Nelson
Sen. Bill NelsonD-FL · Jul 21, 2009

Mr. President, last year we were all transfixed by the non-stop news coverage of Hurricanes Gustav and Ike as they grew into monster storms, crossing the Caribbean and Gulf of Mexico and leaving a…

Olympia J. Snowe
Sen. Olympia J. SnoweR-ME · Jul 21, 2009

Mr. President, as Ranking Member of the Senate Committee on Small Business and Entrepreneurship, I rise to introduce this bill in order to correct disparities among the Small Business…

Claire McCaskill
Sen. Claire McCaskillD-MO · Jul 21, 2009

Mr. President, today I am here to talk about a simple bill that would correct a serious injustice. Each year U.S. consumers spend $2.57 billion more than they should for gasoline and diesel fuel.…

Roland  Burris
Sen. Roland Burris D-IL · Jul 21, 2009

Mr. President, today I rise to address a growing problem resulting from America's high levels of unemployment and economic downturn. Congress is working to design health reform that will provide…

Show 1 more
Russell D. Feingold
Sen. Russell D. FeingoldD-WI · Jul 21, 2009

Mr. President, today I am introducing a bill that would charge a reinspection fee for goods that fail FDA inspection for good manufacturing practices. Currently, businesses do not have to pay for the…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued July 21, 2009

II

111th CONGRESS

1st Session

S. 1477

IN THE SENATE OF THE UNITED STATES

July 21, 2009

Mr. Feingold introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To establish a user fee for follow-up reinspections under the Federal Food, Drug, and Cosmetic Act.

1.

Establishment of user fee for follow-up reinspections

(a)

In general

The Secretary shall assess and collect a user fee from each facility registered under section 415 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350d), establishment registered under section 510 of such Act (21 U.S.C. 360), and facility described in section 351(a)(1)(C) of the Public Health Service Act (42 U.S.C. 262(1)(C)) for which a follow-up reinspection is required to ensure correction of a violation found by the Secretary during initial inspection of the facility or establishment of a good manufacturing practices requirement under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.).

(b)

Payment of fee

The user fee required under subsection (a) shall be due from a facility or establishment described in such subsection upon the reinspection of such facility or establishment, as described in subsection (a).

(c)

Amount of user fee

The amount of the user fee required under subsection (a) shall be established by the Secretary.

(d)

Definitions

For purposes of this section—

(1)

the terms animal drug, device, drug, and food have the meanings given those terms in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321);

(2)

the term biological product has the meaning given the term in section 351 of the Public Health Service Act (42 U.S.C. 262); and

(3)

the term Secretary means the Secretary of Health and Human Services.